These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26113256)

  • 1. Utility of the INECO frontal screening (IFS) in the detection of executive dysfunction in patients with relapsing-remitting multiple sclerosis (RRMS).
    Bruno D; Torralva T; Marenco V; Ardilla JT; Baez S; Gleichgerrcht E; Sinay V; Roca M
    Neurol Sci; 2015 Nov; 36(11):2035-41. PubMed ID: 26113256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Executive Dysfunction with the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS): normative values from a healthy sample and clinical utility in Alzheimer's disease.
    Moreira HS; Lima CF; Vicente SG
    J Alzheimers Dis; 2014; 42(1):261-73. PubMed ID: 24840570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of IFS (INECO Frontal Screening) for the detection of executive dysfunction in adults with bipolar disorder and ADHD.
    Baez S; Ibanez A; Gleichgerrcht E; Perez A; Roca M; Manes F; Torralva T
    Psychiatry Res; 2014 May; 216(2):269-76. PubMed ID: 24582774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of the INECO frontal screening (IFS) in the detection of patients with traumatic brain injury presenting executive deficits.
    Pinasco C; Oviedo M; Goldfeder M; Bruno D; Lischinsky A; Torralva T; Roca M
    Appl Neuropsychol Adult; 2023; 30(3):289-296. PubMed ID: 34156897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INECO frontal screening: an instrument to assess executive dysfunction in schizophrenia.
    Silva T; Monteiro L; Lopes E
    Span J Psychol; 2014; 17():E19. PubMed ID: 25012692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A brief neuropsychological screening test battery for cognitive dysfunction in Brazilian multiple sclerosis patients.
    Negreiros MA; Mattos P; Landeira-Fernandez J; Paes RA; Alvarenga RP
    Brain Inj; 2008 May; 22(5):419-26. PubMed ID: 18415722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the clinical usefulness of the Institute of Cognitive Neurology (INECO) Frontal Screening (IFS) and the Frontal Assessment Battery (FAB) in frontotemporal dementia.
    Gleichgerrcht E; Roca M; Manes F; Torralva T
    J Clin Exp Neuropsychol; 2011 Nov; 33(9):997-1004. PubMed ID: 21923634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INECO Frontal Screening (IFS): a brief, sensitive, and specific tool to assess executive functions in dementia.
    Torralva T; Roca M; Gleichgerrcht E; López P; Manes F
    J Int Neuropsychol Soc; 2009 Sep; 15(5):777-86. PubMed ID: 19635178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust regional cerebral blood flow perfusion deficits in relapsing-remitting multiple sclerosis patients with executive function impairment.
    Messinis L; Apostolopoulos D; Spiridonidis T; Nasios G; Giazkoulidou A; Tsolaki M; Panagiotopoulos V
    Hell J Nucl Med; 2019; 22 Suppl():147-159. PubMed ID: 30877732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinguishing mild cognitive impairment from healthy aging and Alzheimer's Disease: The contribution of the INECO Frontal Screening (IFS).
    Moreira HS; Costa AS; Machado Á; Castro SL; Lima CF; Vicente SG
    PLoS One; 2019; 14(9):e0221873. PubMed ID: 31504056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of the Diagnosis of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis.
    Borkowska AR; Daniluk B; Adamczyk K
    Int J Environ Res Public Health; 2021 Oct; 18(19):. PubMed ID: 34639827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Daum I; Wiltfang J; Berlit P; Diehl RR; Abdel-Hamid M
    J Neuropsychol; 2013 Mar; 7(1):91-106. PubMed ID: 23126275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis.
    Kraemer M; Herold M; Uekermann J; Kis B; Wiltfang J; Daum I; Dziobek I; Berlit P; Diehl RR; Abdel-Hamid M
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1016-22. PubMed ID: 23199520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
    Roca M; Manes F; Gleichgerrcht E; Ibáñez A; González de Toledo ME; Marenco V; Bruno D; Torralva T; Sinay V
    Cogn Behav Neurol; 2014 Mar; 27(1):25-30. PubMed ID: 24674963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional reduction in cortical blood flow among cognitively impaired adults with relapsing-remitting multiple sclerosis patients.
    Hojjat SP; Cantrell CG; Vitorino R; Feinstein A; Shirzadi Z; MacIntosh BJ; Crane DE; Zhang L; Morrow SA; Lee L; O'Connor P; Carroll TJ; Aviv RI
    Mult Scler; 2016 Oct; 22(11):1421-1428. PubMed ID: 26754799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.